Bansal N, Kathuria D, Babu A, Dhiman S, Lakhanpal S, Prasad K
RSC Med Chem. 2025; .
PMID: 39925732
PMC: 11803303.
DOI: 10.1039/d4md00720d.
Bell V, Rodrigues A, Antoniadou M, Peponis M, Varzakas T, Fernandes T
Nutrients. 2023; 15(23).
PMID: 38068758
PMC: 10708094.
DOI: 10.3390/nu15234900.
Chen X, Li X, Zhang K, Lian K, Zhang W, Song Y
Clin Exp Nephrol. 2023; 28(2):125-135.
PMID: 37847437
DOI: 10.1007/s10157-023-02413-2.
Aithal G, Palaniyappan N, China L, Harmala S, Macken L, Ryan J
Gut. 2020; 70(1):9-29.
PMID: 33067334
PMC: 7788190.
DOI: 10.1136/gutjnl-2020-321790.
Mortensen L, Bistrup C, Thiesson H
Front Med (Lausanne). 2017; 4:210.
PMID: 29226122
PMC: 5705552.
DOI: 10.3389/fmed.2017.00210.
Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials.
Bapoje S, Bahia A, Hokanson J, Peterson P, Heidenreich P, Lindenfeld J
Circ Heart Fail. 2013; 6(2):166-73.
PMID: 23403436
PMC: 3893922.
DOI: 10.1161/CIRCHEARTFAILURE.112.000003.
Effect of spironolactone on acid and alkaline phosphatase in the testes of albino rat.
Singh P, Singh D
Indian J Clin Biochem. 2012; 20(1):115-7.
PMID: 23105506
PMC: 3454152.
DOI: 10.1007/BF02893054.
Spironolactone and colitis: increased mortality in rodents and in humans.
Johnson L, Govani S, Joyce J, Waljee A, Gillespie B, Higgins P
Inflamm Bowel Dis. 2011; 18(7):1315-24.
PMID: 22081497
PMC: 3288762.
DOI: 10.1002/ibd.21929.
Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.
Wenzl H, Fine K, Santa Ana C, Porter J, Fordtran J
Dig Dis Sci. 1997; 42(1):119-28.
PMID: 9009126
DOI: 10.1023/a:1018897307835.
Corticosteroid receptor antagonists: a current perspective.
Sutanto W, de Kloet E
Pharm World Sci. 1995; 17(2):31-41.
PMID: 7795556
DOI: 10.1007/BF01875052.
Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
Regardh C, Jordo L, ERVIK M, Lundborg P, Olsson R, Ronn O
Clin Pharmacokinet. 1981; 6(5):375-88.
PMID: 7333059
DOI: 10.2165/00003088-198106050-00004.
Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency.
McInnes G, Harrison I, Shelton J, PERKINS R
Br J Clin Pharmacol. 1981; 12(5):743-7.
PMID: 7332740
PMC: 1401948.
DOI: 10.1111/j.1365-2125.1981.tb01299.x.
Comparison of single and divided daily dose spironolactone in the control of hypertension.
Bell G, Fananapazir L, ANDERTON J
Br J Clin Pharmacol. 1981; 12(4):585-8.
PMID: 7295494
PMC: 1401883.
DOI: 10.1111/j.1365-2125.1981.tb01271.x.
Spironolactone dose-response relationships in healthy subjects.
McInnes G, PERKINS R, Shelton J, Harrison I
Br J Clin Pharmacol. 1982; 13(4):513-8.
PMID: 7066166
PMC: 1402049.
DOI: 10.1111/j.1365-2125.1982.tb01413.x.
Systolic time intervals during spironolactone treatment of digitalized and non-digitalized patients with ischaemic heart disease.
Waldorff S, Berning J, Buch J, Steiness E
Eur J Clin Pharmacol. 1982; 21(4):269-73.
PMID: 7056270
DOI: 10.1007/BF00637612.
Effect of spironolactone on systemic blood pressure, limb blood flow and response to sympathetic stimulation in hypertensive patients.
Clement D
Eur J Clin Pharmacol. 1982; 21(4):263-7.
PMID: 7035184
DOI: 10.1007/BF00637611.
Resistance to diuretics: emphasis on a pharmacological perspective.
Brater D
Drugs. 1981; 22(6):477-94.
PMID: 7032875
DOI: 10.2165/00003495-198122060-00004.
The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol.
Fernandez M, Carter G, Palmer T
Br J Clin Pharmacol. 1983; 15(1):95-101.
PMID: 6849751
PMC: 1427833.
DOI: 10.1111/j.1365-2125.1983.tb01470.x.
Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience.
McInnes G, Shelton J, Ramsay L, Harrison I, Asbury M, Clarke J
Br J Clin Pharmacol. 1982; 13(3):331-9.
PMID: 6460516
PMC: 1402118.
DOI: 10.1111/j.1365-2125.1982.tb01383.x.
Effect of spironolactone on p-nitrophenol glucuronidation in isolated rat hepatocytes.
Guibert E, Morisoli L, Monti J, RODRIGUEZ GARAY E
Experientia. 1983; 39(5):527-8.
PMID: 6406259
DOI: 10.1007/BF01965189.
